A B S T R A C T Impaired renal tubular transport of proline, hydroxyproline, and glycine was inherited as an autosomal recessive trait in two Ashkenazi-Jewish pedigrees and one FrenchCanadian family; the heterozygotes for the trait exhibited hyperglycinuria only. Intestinal transport of imino acids and glycine was not impaired in homozygotes. It is possible that more than one mutant allele may occur at a locus controlling tubular transport of the imino acids and glycine, since one subject with the imino-glycinuric phenotype had one parent who was not hyperglycinuric.
More than 60% of the specific tubular transport function is still available in homozygotes for absorption of imino acids and glycine at endogenous substrate concentrations; however, this persistent transport is already saturated at these concentrations in contrast to the large capacity available in normal subjects. Furthermore, the glycine portion of this persistent transport is noninhibitable by imino acids in contrast to the normal situation. The imino acids can inhibit each other's uptake in mutant and normal phenotypes. Two modes of
INTRODUCTION
The mammalian kidney absorbs the imino acids, L-proline and 4-hydroxy-L-proline, and the amino acid glycine from the glomerular filtrate by at least one tubular transport agency, which is common to these particular solutes (1) (2) (3) (4) . The specificity of the transport system is made apparent only when the concentrations in plasma are raised above their normal endogenous levels; the system is saturable and either imino acid will competitively inhibit the uptake of the other two substrates. Any transport agency with this capacity for discrimination presumably has a structural specificity to account for its function. This specificity will be genetic in origin and, hence, mutations affecting it may be anticipated.
This report describes three unrelated pedigrees in which the homozygous form of a recessively inherited phenotoype shows impaired tubular absorption of the imino acids and glycine; the heterozygous phenotype shows hyperglycinuria alone.
It was noted that the homozygote nonetheless retains considerable absorptive activity towards the imino acids and glycine under the usual endogenous conditions; the most likely explanation for this paradox is that more than one type of transport exists for imino acids and glycine in human kidney, only one of which is affected by the mutation (5) . In the interval, after preliminary publication of the results found in one pedigree (5, 6) , two additional pedigrees have been discovered. New considerations of the genetic basis of this transport mutation, additional studies of the kinetics of transport in normal and mutant subjects, and information on the organization of membrane transport systems, whereby more than one mechanism is apparently available to a single substrate, are presented in this communication.
METHODS

Subjects PEDIGREE A
The propositus (A,II,2) of this pedigree (Fig. 1A) is a healthy Ashkenazi Jewish white male, whose mother (A,I,2) died with cirrhosis and malignant hepatoma (7) . Investigations of the family for a possible metabolic disorder led to the discovery of imino-glycinuria in the propositus. All living individuals studied in this pedigree are healthy.
PEDIGREE B
The propositus (B,II,1) for this pedigree (Fig. 1B) is a white Caucasian male infant of French-Canadian origin; the presenting diagnosis was cystinosis. Investigation of the family led to the incidental discovery of specific hyperaminoaciduria in the mother, who is otherwise healthy, and in other relatives.
PEDIGREE C
The propositus (C,III,2) of this pedigree (Fig. 1C ) is a five month old Ashkenazi Jewish male infant discovered through routine screening to have cystathioninuria and hyperglycinuria. Investigation of the family revealed that his mother has imino-glycinuria; she is otherwise healthy.
Materials. Chromatographically pure L-proline and hydroxy-L-proline (obtained from Mann Research Laboratories, New York) were used for the i.v. infusions. Purity was confirmed by chromatographic methods and the solutions were prepared for infusion as described previously (1, 2) . L-proline, hydroxyproline-free (obtained from Nutritional Biochemical Corp., Cleveland, Ohio), which was used for the loading tests was given by mouth.
Techniques. Amino acid content and endogenous clearance rates of amino acids were estimated in the overnight-fasted state in the manner previously described (1, 2, 8) ; random or 24-hr urine collections were not used. L-proline was infused i.v. into subj ects A,II,2, A,II,3, and B,I,4, and hydroxy-L-proline was infused separately into subjects A,II,2 and A,II,3, in order to achieve an estimate of their respective maximum rates of tubular absorption (Tm) (1, 2) . Intestinal absorption of L-proline was evaluated in subjects A,II,2 and B,II,7, and in two healthy adult males matched for weight and age. After an overnight fast and withdrawal of a control sample of venous blood, L-proline was given by mouth (100 mg/kg), after which venous blood was obtained at hourly intervals.; the concentration of proline was measured in these samples. All samples were prepared for analysis by procedures described elsewhere (1, 2, 8) .
ANALYTICAL METHODS
Qualitative. The amino acid content of urine aliquots, equivalent to 250 ,tg of total nitrogen, was evaluated by ascending partition chromatography on 10-inch square No. 4 Whatman filter paper, developed in two dimensions, first in phenol, then in lutidine (9) . The chromatograms were stained with a ninhydrin-isatin mixture (10) and were read immediately with transmitted light, and again 24 hr later. The chromatograms were then overstained with Ehrlich's reagent to enhance the detection of hydroxyproline (11) . The presence (abnormal) or absence (normal) of iminoaciduria (proline and hydroxyproline) in human subjects beyond early infancy is reliably determined under these conditions. The criteria for "hyperglycinuria" are more difficult to define, since glycinuria is a normal phenomenon; the diagnosis of "hyperglycinuria" was considered if three experienced observers considered the glycine spot on the partition chromatogram to be excessive. The quantitative criteria for "hyperglycinuria" in the fasted state were: a concentration in urine exceeding 0.16 umole/mg of total nitrogen; or an endogenous clearance rate exceeding 8.6 ml/min per 1.73 m2. These maxima were defined in earlier investigations and publications (1, 8 (14) . Inulin in urine and plasma was determined by the method of Bojesen (15) .
RESULTS
Inheritance of the imino-glycinuric phenotype. More than one form of hyperaminoaciduria appears in each of the pedigrees (Fig. 1) 1 Illustrations of three pedigrees, which contain otherwise healthy members, with impaired tubular transport of proline, hydroxyproline, and glycine (iminoglycinuria). The phenotype is inherited in an autosomal recessive manner. The concentration in plasma of the affected amino acids is normal; the function of a specific tubular transport system common to them (1-4) is presumably impaired by the mutation. Subjects A,II,2, B,II,7, and C,II,2 each have parents and offspring with hyperglycinuria, but no iminoaciduria. The latter is therefore considered to be the heterozygous phenotype; iminoglycinuria presumably represents the homozygous phenotype. One subject (A,III,-12) has only one hyperglycinuric parent; he is possibly heteroallelic for two different mutations at one locus controlling the imino-glycine transport system. in each of the pedigrees, reminiscent of a similar trait found in an Ashkenazi-Jewish pedigree by DeVries, Kochwa, Lazebnik, Frank, and Djaldetti (16) . In each of our pedigrees a second trait is represented by abnormal urinary excretion of glycine and the imino acids, proline, and hydroxyproline. All offspring of imino-glycinuric subjects are hyperglycinuric; the parents of these individuals are also hyperglycinuric (Pedigrees B and C, Fig. 1 and Table I ). The segregation of the two traits is, therefore, such as to suggest that the hyperglycinuric subjects are the heterozygotes for a mutant allele which in the homozygous form is accompanied by an imino-glycinuric phenotype. Glycine clearance rates were measured wherever possible; this was of importance primarily in subject A,I,1 who should exhibit the hyperglycinuric trait, but did so unequivocally only in terms of his glycine clearance rate.
One patient raises important interpretative difficulties. Subject AJII,12 exhibited consistent imino-glycinuria (comparable to subjects A,II,4, B,IJ,7, and C,III,2) on three occasions within a 1 yr period (2%/2-3/2 yr of age). His father (A,II,4) has the hyperglycinuric trait; however, his mother (AII,5) has normal aminoaciduria. She was studied on three occasions during the same period (Table I) ble II). Therefore, it is possible that this is a "silent" trait in this woman which represents a second mutant allele only made apparent in her son, AJII,12. If this is the case, the son could be considered heteroallelic for two mutations at the same locus on the gene. Mechanism of the hyperaminoaciduria. The endogenous renal clearance rates of proline, hydroxyproline, and glycine are usually greatly increased in the homozygote (Table II) , although the concentration of each compound in plasma is normal; diminished net tubular reabsorption is thus evident (Table II) . Nonetheless, the loss of tubular absorption of these three solutes is not complete; the majority of the endogenous filtered load is still absorbed in the mutant homozygous phenotype (Table II) .
Tubular absorption of both imino acids is complete in heterozygotes. The renal clearance of glycine is greater than normal in these subjects, but The infusion of L-proline in the mutant homozygote, A,II,2, demonstrated that there was no further capacity for proline absorption in this subject beyond that operative at the endogenous concentration of proline in plasma (Fig. 3) ; the low Tm value (Fig. 3 and Table III) indicates the loss of the high capacity (Tm) system which is normally present (1). The Tm-proline value and the venous plasma threshold for prolinuria in the homozygote were both about one-tenth of that measured in normal subjects (1) .
In the heterozygote. The Tm-proline values obtained in the heterozygotes, A,II,3 and BJ,2,
were intermediate between those of the mutant homozygote and those of the normal subjects ( Fig. 3 and Table III ). There was no splay in the absorption rate at low filtered amounts of proline before achieving the Tm; this suggests that the affinity for substrate is probably not different from the normal affinity.
Transport of hydroxy-L-proline In the homozygote. i.v. infusion of hydroxyproline produced an effect analagous to that of an inTransport of Imino Acids and Glycine in Kidney The endogenous renal clearance of proline is dependent on the concentration of proline in plasma in mutant homozygotes (circles, B,II,7; squares, AII,2) as in normal subjects (1) . The points of emphasis in this graph are: (a) the renal clearance of proline is negligible at low plasma levels, which is thus indicative of a persistent absorptive function in the homozygous phenotype; (b) the threshold for abnormal proline clearance is about one-fifth of that for normal subjects (1).
fusion of L-proline. The homozygote (A,II,2) exhibited no additional capacity to transport hydroxy-L-proline at filtered loads beyond the existing endogenous capacity (Fig. 4 and Table III ).
In the heterozygote. The heterozygous subject AII,3, had a reduced capacity to transport hydroxy-L-proline (Fig. 4 and Table III ) when compared with the normal subjects (2), but the capacity was greater than in the homozygote. There was no splay in the absorption rate at low concentrations of substrate.
Transport of glycine
The normal subject absorbs about 95% of the filtered load of glycine (8) Intestinal transport The fecal content of amino acids was examined in one homozygote (A,II,2) while on a normal diet, and again after 5 days on Neomycin (50 mg b.i.d.) by mouth and while receiving a high protein diet containing gelatin supplements. On neither occasion was the amount of proline, hy- FIGURE 4 The maximum rate of tubular absorption of hydroxy-L-proline (Tm hypro) for normal subjects (2) , and the same heterozygous and homozygous subjects depicted in Fig. 3 . The Tm hypro of the heterozygote is intermediate between normal and mutant homozygote values; uptake of hydroxyproline is virtually saturated at the endogenous filtered load in the homozygote. There is no "splay" in the mutant _ absorption curves. droxyproline, or glycine noted in the feces in ex-A,IJ,2 and BJI,7, after they had received L-process of that in normal feces.
line (100 mg/kg) by mouth (Fig. 7) , was equivaThe postabsorptive concentration of L-proline lent to that observed in the normal subjects studin plasma of the two mutant homozygous subjects, ied here and by other investigators (18, 19) . Shaded areas indicate responses observed in normal subjects (data derived from previous studies, references 1 and 2).
was evident that cellular uptake of these solutes by many different tissues is mediated wholly, or in part, by a transport agency with preference for them (1) (2) (3) (4) (20) (21) (22) (23) . Several investigators have now observed sibships or families (18, 19, 24, 25 and footnotes 2 and 3) in which iminoglycinuria persisted beyond the period of infancy when this is a normal phenomenon (23) . In some of these families the imino-glycinuric phenotype was associated with mental retardation or convulsions (19, 24, 25 
>C
The possibility that the imino-glycinuric mutation is in fact quite common should be considered in view of its widespread occurence in several races and ethnic groups. Three subjects with the trait have been found among about 10,000 who were investigated in the past 6 yr in Montreal. Although this gives no indication of the true frequency of the trait, it would appear to be relatively common. Heterogeneity of the trait with the possibility that heteroallelic subjects do occur has been proposed to account for the phenotypic relationships of subject AIJJ,12 and his parents, AJI,4 and A,II,5. The phenomenon of heteroalleleism has already been carefully documented in cystinuria by Rosenberg (26) following the discovery of more than one genotype in classical cystinuria (27, 28) . If mutations occur at multiple alleles within a single genetic locus, then one may also predict the discovery of genetic and phenotypic heterogeneity for other heritable disorders of amino acid transport (29) .
The likelihood that more than one miode of transport participates in the tubular absorption of imino acids and glycine has been raised by the present investigation. The hyperimino-glycinuric trait observed in our pedigrees can be attributed to a genetic modification of a group-specific site at which the three solutes mutally interact during uptake into the tubular cell (1-4) ; other mechanisms of interference with transport, such as saturation with substrate and competition from inhibitors at the transport site (1-4, 29) , do not apply in this instance. Despite the apparent deletion of this transport system, the mutant homozygote loses only a portion of his endogenous tubular transport function. When we became aware of this seeming paradox, we reviewed available data (30) on the other heritable disorders of renal transport of amino acids (29) to see if this phenomenon also occured in their homozygous phenotypes. In classical cystinuria, in hypercytinuria (31) , and in Hartnup disease, the homozygote retains an important fraction of his endogenous transport function (30) .
The explanation of this phenomenon now seems apparent, at least in the imino-glycinuric trait; presumably a similar interpretation could be extended to the other mutant transport phenotypes. The normal capacity, Tm, of the intact wild-type tubular transport system common to the imino acids and glycine is at least 10-fold greater than the normal endogenous load (1, 2) , and the affinity of this system is greater for the imino acids than for glycine (1) (2) (3) (4) . Imino-glycinuria occurs in the mutant homozygote because this system is functionally deleted; partial deletion of the system in the heterozygote compromises glycine transport because of the heirarchy of substrate affinity for the system. The paradox raised by the homozygote that nonetheless still absorbs the majority of the filtered endogenous load of imino acids and glycine, can be resolved by proposing one of two alternatives: either the affinity of the common system for its substrates has been altered bv the nmutation-persistent transport thus reflects reduced efficiency for uptake by the modified common system; or, there may be complete functional deletion of the common system, with subsequent unmasking of an alternate mode of transport which has different kinetic characteristics. There is no evidence supporting the first alternative, and the second explanation can account for. all of the observations reported herein.
Certain characteristics of the residual mode of transport are evident. It has a low capacity and high affinity for substrate. It is saturated at the endogenous concentrations (in plasma) of its substrate (Figs. 3 and 4) and, hence, the capacity for these substrates can be estimated (Table V) .
The ability of this second mode to transport substrate with high efficiency is evident in subjects BII,7 (Table I) and B,II,9 (Fig. 2) . Considerable substrate specificity is evident, first from the inability of imino acids to compete with glycine ( Fig. 5) , and second, from their interactions with each other, suggests that the imino acids share a low-capacity system distinct from the glycine system (Fig. 6) mouse bone (21) , human kidney (34), as well as micro organisms (32, 35) , and yeasts (36) . The present investigation is, however, the first opportunity to demonstrate the evidence in vivo in man.
If heterogeneity of transport is a phenomenon of more universal than particular significance, then mutations affecting the low-capacity, substrate-specific systems can be anticipated and sought in man. In this regard, human hypercystinuria (31) is probably the phenotype for a mutant cystine-specific transport system, in contrast to "classical" cystinuria in which a group-specific agency is involved. The recent discovery in our laboratory of hyperalaninuria and hyperlysinuria in different families 4 substantiates our belief that it is only a matter of time before most of the predictably specific transport defects will be recognized. The presumed disorders of methionine (37) and tryptophan (38) absorption could be claimed 4 Scriver and Whelan. Unpublished observations. now as examples wherein the relevant substratespecific transport agency in the intestine is affected.
Simultaneous manifestation of the mutant transport phenotype in kidney and in gut has been demonstrated in cystinuria (39) and in Hartnup disease (12, 40) . However, it is also known that, whereas some mutant transport genotypes are accompanied by an intestinal transport defect, others were not (26, 28) . Two of our imino-glycinuric homozygotes with a renal transport defect had no intestinal transport defect; Rosenberg 3 has made a similar observation in another iminoglycinuric pedigree. On the other hand, an intestinal transport defect has been found in other iminoglycinuric families (18, 19) . On such preliminary evidence, one can plead for heterogeneity of the imino-glycinuric genotype.
The foregoing investigations provide a body of data which implicate a complex organization of membrane transport systems used by the imino acids and glycine (Table V) ; the present interpreTransport of Imino Acids and Glycine in Kidney 833 tation may, however, change as more pedigrees carrying the mutant imino-glycinuric phenotype are discovered and investigated.
